Concepedia

Akshjot Puri

AP

Statistics

Publications

3

Citations

42

H-Index

3

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Houston Methodist

Banner MD Anderson Cancer Center

Akshjot Puri is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, immune checkpoint inhibitors, and cytotoxic t-lymphocyte antigen 4 (ctla-4) pathway.

ORCID

Publications per year

2017–2024

3

Publications

3

The safety of pembrolizumab in metastatic melanoma and rheumatoid arthritis

Akshjot Puri, Jade Homsi · Melanoma Research · 2017 · 17 citations

, , +17

NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression

T. P. Reddy, Akshjot Puri, Liliana Guzman‐Rojas et al. · Nature Communications · 2024 · 13 citations · Full text

, , +17

Skeletal metastases in advanced pancreatic ductal adenocarcinoma: a retrospective analysis

Akshjot Puri, John C. S. Chang, Natalee Tanner et al. · Journal of Gastrointestinal Oncology · 2021 · 12 citations · Full text

, , +17

1–3 of 3